Cover Image
Market Research Report
Product code 
1071605

Europe Proteomics Market Forecast 2022-2030

Published: | Inkwood Research | 150 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Proteomics Market Forecast 2022-2030
Published: April 26, 2022
Inkwood Research
Content info: 150 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The Europe proteomics market is set to record a CAGR of 14.05% during the forecast period, 2022-2030. The government initiatives boost market demands. For instance, the European Union's Horizon 2020 program to develop and sustain proteomics exploration for all science researchers in the European Union.

MARKET INSIGHTS

France, Germany, the United Kingdom, Belgium, Poland, Italy, Spain, and Rest of Europe are analyzed for the Europe proteomics market growth assessment. Germany has eminent research institutes, major market players, and world-class facilities, in terms of science and technology. It is known for its technological innovations, skilled workforce, and industry leadership, thereby attracting investments. The Max Planck Institute of Biochemistry (MPIB) in Martinsried, Munich, is a leading international research institution that conducts related research and studies on proteomics.

Further, as of March 2022, the researchers at MPIB discovered acute myeloid leukemia, the first proteomic subtype of aggressive blood cancer, along with collaborating partners, through mass spectrometry technology. In Italy, the National Research Council (CNR) is the largest public research institution that undertakes multidisciplinary activities. Whereas, Belgium is home to small SMEs, large pharma or agro companies, and academic research centers. Also, activities and initiatives by leading research universities are the important drivers propelling the biotech sector.

In addition, the country encompasses key research activities by the top pharma companies, including Janssen Pharmaceutica, GSK, Sanofi, Pfizer, Novartis, etc. The strategic developments between these prominent players and emerging biotech companies further propel the sector's development. Such factors boost market demands in these countries.

COMPETITIVE INSIGHTS

Some of the key companies in the market include: Japan Electron Optics Laboratory Co Ltd (JOEL), Danaher Corporation, Fios Genomics, Creative Proteomics, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 24608

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. ADVANCES IN PROTEOMICS STUDY AND ITS WIDE-SCALE APPLICATIONS
    • 3.1.2. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGHLY EXPENSIVE SERVICES AND INSTRUMENTATION
    • 3.2.2. LOW UNIFIED EFFORTS AND INITIATIVES BY GOVERNMENTS AND OTHER ORGANISATIONS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON PROTEOMICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. KEY BUYING CRITERIA

5. MARKET BY COMPONENTS

  • 5.1. REAGENTS
    • 5.1.1. IMMUNOASSAY
    • 5.1.2. SPECTROSCOPY
    • 5.1.3. MICROARRAY
    • 5.1.4. X-RAY CRYSTALLOGRAPHY
    • 5.1.5. ELECTROPHORESIS
    • 5.1.6. CHROMATOGRAPHY
    • 5.1.7. PROTEIN FRACTIONATION REAGENTS
  • 5.2. INSTRUMENTS
    • 5.2.1. PROTEIN MICROARRAY
    • 5.2.2. SPECTROSCOPY
      • 5.2.2.1. MASS SPECTROMETRY
      • 5.2.2.2. NMR SPECTROMETRY
    • 5.2.3. CHROMATOGRAPHY
      • 5.2.3.1. HPLC SYSTEMS
      • 5.2.3.2. AFFINITY CHROMATOGRAPHY
      • 5.2.3.3. SUPERCRITICAL FLUID CHROMATOGRAPHY
      • 5.2.3.4. ION CHROMATOGRAPHY
    • 5.2.4. SURFACE PLASMON RESONANCE
    • 5.2.5. ELECTROPHORESIS
    • 5.2.6. PROTEIN FRACTIONATION REAGENTS
    • 5.2.7. X-RAY CRYSTALLOGRAPHY
  • 5.3. SERVICES

6. MARKET BY APPLICATION

  • 6.1. DRUG DISCOVERY
  • 6.2. DISEASE DIAGNOSIS
  • 6.3. OTHER APPLICATIONS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED KINGDOM
      • 7.1.5.2. GERMANY
      • 7.1.5.3. FRANCE
      • 7.1.5.4. ITALY
      • 7.1.5.5. SPAIN
      • 7.1.5.6. BELGIUM
      • 7.1.5.7. POLAND
      • 7.1.5.8. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS
  • 8.2. COMPANY PROFILES
    • 8.2.1. AGILENT TECHNOLOGIES INC
    • 8.2.2. BIOGNOSYS AG
    • 8.2.3. BIO-RAD LABORATORIES
    • 8.2.4. BRUKER CORPORATION
    • 8.2.5. CREATIVE PROTEOMICS
    • 8.2.6. DANAHER CORPORATION
    • 8.2.7. FIOS GENOMICS
    • 8.2.8. JAPAN ELECTRON OPTICS LABORATORY CO LTD (JOEL)
    • 8.2.9. MS BIOWORKS
    • 8.2.10. PERKINELMER INC
    • 8.2.11. PROMEGA CORPORATION
    • 8.2.12. SENGENICS
    • 8.2.13. SHIMADZU
    • 8.2.14. THERMO FISHER SCIENTIFIC INC
    • 8.2.15. WATERS CORPORATION

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PROTEOMICS
  • TABLE 2: EUROPE PROTEOMICS MARKET, BY COMPONENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: EUROPE PROTEOMICS MARKET, BY COMPONENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: EUROPE PROTEOMICS MARKET, BY REAGENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: EUROPE PROTEOMICS MARKET, BY REAGENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: EUROPE PROTEOMICS MARKET, BY INSTRUMENTS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: EUROPE PROTEOMICS MARKET, BY INSTRUMENTS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: EUROPE PROTEOMICS MARKET, BY SPECTROSCOPY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: EUROPE PROTEOMICS MARKET, BY SPECTROSCOPY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: EUROPE PROTEOMICS MARKET, BY CHROMATOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: EUROPE PROTEOMICS MARKET, BY CHROMATOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: EUROPE PROTEOMICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: EUROPE PROTEOMICS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 14: EUROPE PROTEOMICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: EUROPE PROTEOMICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 16: KEY PLAYERS IN EUROPE PROTEOMICS MARKET
  • TABLE 17: LIST OF MERGERS & ACQUISITIONS
  • TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 20: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY BUYING CRITERIA
  • FIGURE 6: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY COMPONENTS, IN 2021
  • FIGURE 7: EUROPE PROTEOMICS MARKET, BY REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 8: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY REAGENTS, IN 2021
  • FIGURE 9: EUROPE PROTEOMICS MARKET, BY IMMUNOASSAY, 2022-2030 (IN $ MILLION)
  • FIGURE 10: EUROPE PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
  • FIGURE 11: EUROPE PROTEOMICS MARKET, BY MICROARRAY, 2022-2030 (IN $ MILLION)
  • FIGURE 12: EUROPE PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 13: EUROPE PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
  • FIGURE 14: EUROPE PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 15: EUROPE PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 16: EUROPE PROTEOMICS MARKET, BY INSTRUMENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 17: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY INSTRUMENTS, IN 2021
  • FIGURE 18: EUROPE PROTEOMICS MARKET, BY PROTEIN MICROARRAY, 2022-2030 (IN $ MILLION)
  • FIGURE 19: EUROPE PROTEOMICS MARKET, BY SPECTROSCOPY, 2022-2030 (IN $ MILLION)
  • FIGURE 20: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY SPECTROSCOPY, IN 2021
  • FIGURE 21: EUROPE PROTEOMICS MARKET, BY MASS SPECTROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 22: EUROPE PROTEOMICS MARKET, BY NMR SPECTROMETRY, 2022-2030 (IN $ MILLION)
  • FIGURE 23: EUROPE PROTEOMICS MARKET, BY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 24: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY CHROMATOGRAPHY, IN 2021
  • FIGURE 25: EUROPE PROTEOMICS MARKET, BY HPLC SYSTEMS, 2022-2030 (IN $ MILLION)
  • FIGURE 26: EUROPE PROTEOMICS MARKET, BY AFFINITY CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 27: EUROPE PROTEOMICS MARKET, BY SUPERCRITICAL FLUID CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 28: EUROPE PROTEOMICS MARKET, BY ION CHROMATOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 29: EUROPE PROTEOMICS MARKET, BY SURFACE PLASMON RESONANCE, 2022-2030 (IN $ MILLION)
  • FIGURE 30: EUROPE PROTEOMICS MARKET, BY ELECTROPHORESIS, 2022-2030 (IN $ MILLION)
  • FIGURE 31: EUROPE PROTEOMICS MARKET, BY PROTEIN FRACTIONATION REAGENTS, 2022-2030 (IN $ MILLION)
  • FIGURE 32: EUROPE PROTEOMICS MARKET, BY X-RAY CRYSTALLOGRAPHY, 2022-2030 (IN $ MILLION)
  • FIGURE 33: EUROPE PROTEOMICS MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 34: EUROPE PROTEOMICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
  • FIGURE 35: EUROPE PROTEOMICS MARKET, BY DRUG DISCOVERY, 2022-2030 (IN $ MILLION)
  • FIGURE 36: EUROPE PROTEOMICS MARKET, BY DISEASE DIAGNOSIS, 2022-2030 (IN $ MILLION)
  • FIGURE 37: EUROPE PROTEOMICS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 38: EUROPE PROTEOMICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 39: UNITED KINGDOM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: GERMANY PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 41: FRANCE PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 42: ITALY PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: SPAIN PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: BELGIUM PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: POLAND PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: REST OF EUROPE PROTEOMICS MARKET, 2022-2030 (IN $ MILLION)